News

Deal Announcements

Axonics Modulation Garners Series A Venture Capital

Thursday, March 27, 2014 5:33:00 AM PDT | VentureDeal
   Irvine, California  --  Medical device company Axonics Modulation Technologies secured $32.6 million in its first round of institutional venture capital funding.

Axonics is developing implantable neuromodulation technology licensed from The Alfred Mann Foundation directed toward the treatment of chronic pain and overactive bladder.

Edmond de Rothschild Investment Partners led the round, which also included NeoMed Management and Legend Ventures.

Axonics said it would use the proceeds to accelerate product development and fund a series of clinical studies for its patented neuromodulation system.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1